Startup Neurophos has secured $110 million in Series A funding, led by Bill Gates’ M12 venture fund, to develop a new type of chip for running AI models. The company claims its technology can outperform current accelerators. CEO Patrick Bowen and M12’s Michael Stewart discussed the round on Bloomberg Tech, signaling strong investor confidence in specialized hardware.

The funding reflects intense competition in the semiconductor space, where companies race to build more efficient chips for AI workloads. Established players like Nvidia dominate the market, but startups are targeting niche performance gains. This round gives Neurophos capital to move from concept toward commercial prototypes, a critical step for any hardware venture.

Investors will watch how Neurophos translates its technology into a viable product against entrenched competitors. The involvement of a high-profile fund like M12 adds credibility, but execution remains the key hurdle. Success could pressure larger chipmakers and influence where future AI infrastructure spending flows, making this a deal to monitor in the coming quarters.